Monoclonal Gammopathy of Undetermined Significance and COVID-19: Results from the Population-Based Iceland Screens Treats or Prevents Multiple Myeloma Study (iStopMM)

Introduction Multiple myeloma (MM) patients have an increased risk of severe coronavirus disease 2019 (COVID-19) when infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Monoclonal gammopathy of undetermined significance (MGUS) precedes MM and related disorders and affects 4....

Descripción completa

Detalles Bibliográficos
Autores principales: Rögnvaldsson, Sæmundur, Eythorsson, Elias, Thorsteinsdottir, Sigrun, Vidarsson, Brynjar, Onundarson, Pall Torfi, Agnarsson, Bjarni Agnar, Sigurdardottir, Margret, Thorsteinsdottir, Ingunn, Olafsson, Isleifur, Runolfsdottir, Hrafnhildur Linnet, Helgason, Dadi, Emilsdóttir, Arna, Bjornsson, Aron H, Kristjansdottir, Gudrun, Thordardottir, Asdis Rosa, Indridason, Olafur Skuli, Jonsson, Asbjorn, Gislason, Gauti Kjartan, Olafsson, Andri, Steingrimsdottir, Hlif, Kampanis, Petros, Hultcrantz, Malin, Durie, Brian G.M., Harding, Stephen, Landgren, Ola, Love, Thorvardur Jon, Palsson, Runolfur, Kristinsson, Sigurdur Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
652.Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701832/
http://dx.doi.org/10.1182/blood-2021-153145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701832/
http://dx.doi.org/10.1182/blood-2021-153145

Ejemplares similares